Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
about
A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1Molecular cloning of the lymphocyte activation marker Blast-1Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinDown-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesEBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Early events associated with infection of Epstein-Barr virus infection of primary B-cellsThe EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growthEpstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Histone acetylation and reactivation of Epstein-Barr virus from latency.Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirusControl of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationDirect and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human seraDifferences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsLytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancerLatent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformationGeneration of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceSrc kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBCD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergenceEpstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 moleculeLow-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells
P2860
Q24323156-5BB2A74E-3A3C-4588-8ECE-AC43F4F576A6Q24339640-0D12B031-945D-47D4-8CDC-55CAEC4737E6Q24564697-41318139-8B45-47C3-96D0-2E2D7DDBB407Q24599252-65083554-5BEC-498E-967D-05E87CD30B43Q24605501-9B4C6A1F-0126-4426-9795-B1E1BAD781E5Q24804219-93487F9E-6B37-42E4-921A-949937C8ADA9Q28476230-F6A50D90-E46E-4463-9A8A-4296E86AD12DQ28546003-EF1C1C3E-B889-49F4-9DBC-631FC330BDB2Q30452167-59FAB426-AC44-4729-B94F-4C5FFF74B5DDQ33657311-154AD7A4-08D1-44F2-BDFD-0C6EA84BFFB6Q33688737-94B40E08-8462-4347-BE9D-1D186406AD4AQ33786088-50A30572-D5E0-49F6-BC24-E3B723668F34Q33792860-F06E80A5-3277-4423-90D1-939806AF94D7Q33796114-CE5ADB6D-6D07-451D-90F1-5CEDEE76026BQ33796173-11F1B59E-EC90-4FF2-B6E2-2573742C8493Q33813615-739934A7-8601-47CB-BFC4-22562EC48A61Q33825713-B1B6616C-A51A-45E3-8B7C-221045292759Q33851043-3147CA44-E109-41CC-90CA-4E95AA2C1AF9Q33880494-6A04E90F-A89F-42CF-A009-90D24CD41171Q33905718-31BB71F2-A7FE-48DC-9113-37A9EABA8D5DQ33929593-41B5B493-EA27-4D26-8207-F9D901831AD6Q34226611-8A05C8B5-A3B8-464B-B4DE-C6BCD3D31E10Q34250209-AA7F064C-1BAF-4AF4-83E0-7FAAC72D5835Q34324039-F1AA8A51-2373-44A8-8673-504F54F1BF53Q34334755-3F5C9A91-D735-43BC-8A49-DB738F3E4F83Q34341875-003F15F3-4A6E-4697-B357-FB88980B8B72Q34374436-15D865C3-A7C3-418F-8592-6A88842A0900Q34465612-B46E71FE-B16F-4E73-9EE3-BDF576E1C53AQ34625121-45B0C636-FBBD-41C6-AD9C-459035D3A20CQ35122447-F142A49C-612E-4503-82D6-4BA32961067AQ35139273-6197B5C4-335B-4E03-97B1-E6E84CC09096Q35147016-5296CE52-403D-42AB-BB69-BC4DD9B9F983Q35155351-2746CE72-D87D-418B-80ED-F7C9C29B78D7Q35291650-6050BED3-D80E-4ED9-A6D0-CEE6A472A3F2Q35363296-9FC263BD-EF58-4496-B92B-E7EEC991AF8AQ35488811-369B2D24-38CC-4ECC-97ED-D3835890D343Q35494359-5E64943D-F5E8-4E1E-BBDD-0A63EE6719ECQ35664999-5C1954A2-1B10-4881-8651-ABCFFD713D93Q35764233-B14913E2-A198-4E1A-9557-2A5CA6D667B1Q35784734-D9C15DF9-2E48-421C-AB45-525FA2E1A17B
P2860
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
@en
type
label
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
@en
prefLabel
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells
@en
P2093
D A Thorley-Lawson
D Staunton
P2860
P304
P407
P577
1985-09-01T00:00:00Z